Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

53 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q3 2021.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 52,983,439 shares of 147,336,360 outstanding shares and own 35.96% of the company stock.
Largest 10 shareholders include Medicxi Ventures Management (Jersey) Ltd (17,923,892 shares), GENERAL ATLANTIC, L.P. (9,681,818 shares), JANUS HENDERSON GROUP PLC (5,607,302 shares), RA CAPITAL MANAGEMENT, L.P. (3,577,094 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,017,873 shares), Cormorant Asset Management, LP (1,727,273 shares), Samsara BioCapital, LLC (1,537,533 shares), BOXER CAPITAL, LLC (1,334,227 shares), BAKER BROS. ADVISORS LP (1,127,273 shares), and VR Adviser, LLC (1,127,272 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.